[HTML][HTML] Should we interfere with the interleukin-6 receptor during COVID-19: what do we know so far?
A Plocque, C Mitri, C Lefèvre, O Tabary, L Touqui… - Drugs, 2023 - Springer
Severe manifestations of COVID-19 consist of acute respiratory distress syndrome due to an
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
A Plocque, C Mitri, C Lefevre, O Tabary, L Touqui… - Drugs, 2023 - search.proquest.com
Severe manifestations of COVID-19 consist of acute respiratory distress syndrome due to an
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
A Plocque, C Mitri, C Lefèvre, O Tabary, L Touqui… - Drugs, 2022 - europepmc.org
Severe manifestations of COVID-19 consist of acute respiratory distress syndrome due to an
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
A Plocque, C Mitri, C Lefèvre, O Tabary, L Touqui… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Severe manifestations of COVID-19 consist of acute respiratory distress syndrome due to an
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
A Plocque, C Mitri, C Lefèvre, O Tabary, L Touqui… - Drugs, 2023 - search.ebscohost.com
Severe manifestations of COVID-19 consist of acute respiratory distress syndrome due to an
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
[HTML][HTML] Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
A Plocque, C Mitri, C Lefèvre, O Tabary, L Touqui… - Drugs, 2023 - ncbi.nlm.nih.gov
Severe manifestations of COVID-19 consist of acute respiratory distress syndrome due to an
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
A Plocque, C Mitri, C Lefèvre, O Tabary, L Touqui… - Drugs, 2022 - europepmc.org
Severe manifestations of COVID-19 consist of acute respiratory distress syndrome due to an
initially local reaction leading to a systemic inflammatory response that results in hypoxia …
initially local reaction leading to a systemic inflammatory response that results in hypoxia …